Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24552772
DOI
10.1158/1535-7163.mct-13-0625
PII: 1535-7163.MCT-13-0625
Knihovny.cz E-resources
- MeSH
- beta Catenin metabolism MeSH
- Zebrafish MeSH
- Neoplasms, Experimental MeSH
- HEK293 Cells MeSH
- Colorectal Neoplasms drug therapy pathology MeSH
- Low Density Lipoprotein Receptor-Related Protein-6 metabolism MeSH
- Humans MeSH
- Monensin pharmacology therapeutic use MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Cell Proliferation drug effects MeSH
- Antibiotics, Antineoplastic pharmacology therapeutic use MeSH
- Gene Expression Regulation, Neoplastic drug effects MeSH
- Wnt Signaling Pathway drug effects MeSH
- Xenograft Model Antitumor Assays MeSH
- Xenopus MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- beta Catenin MeSH
- Low Density Lipoprotein Receptor-Related Protein-6 MeSH
- Monensin MeSH
- Antibiotics, Antineoplastic MeSH
The Wnt signaling pathway is required during embryonic development and for the maintenance of homeostasis in adult tissues. However, aberrant activation of the pathway is implicated in a number of human disorders, including cancer of the gastrointestinal tract, breast, liver, melanoma, and hematologic malignancies. In this study, we identified monensin, a polyether ionophore antibiotic, as a potent inhibitor of Wnt signaling. The inhibitory effect of monensin on the Wnt/β-catenin signaling cascade was observed in mammalian cells stimulated with Wnt ligands, glycogen synthase kinase-3 inhibitors, and in cells transfected with β-catenin expression constructs. Furthermore, monensin suppressed the Wnt-dependent tail fin regeneration in zebrafish and Wnt- or β-catenin-induced formation of secondary body axis in Xenopus embryos. In Wnt3a-activated HEK293 cells, monensin blocked the phoshorylation of Wnt coreceptor low-density lipoprotein receptor related protein 6 and promoted its degradation. In human colorectal carcinoma cells displaying deregulated Wnt signaling, monensin reduced the intracellular levels of β-catenin. The reduction attenuated the expression of Wnt signaling target genes such as cyclin D1 and SP5 and decreased the cell proliferation rate. In multiple intestinal neoplasia (Min) mice, daily administration of monensin suppressed progression of the intestinal tumors without any sign of toxicity on normal mucosa. Our data suggest monensin as a prospective anticancer drug for therapy of neoplasia with deregulated Wnt signaling.
References provided by Crossref.org
Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells
Wnt Signaling Inhibition Deprives Small Intestinal Stem Cells of Clonogenic Capacity